-
2024SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency., J Exp Med 2024 Sep; 221(9): .
-
2024Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation., J Clin Immunol 2024 Aug; 44(8): 185.
-
2023Dissecting human population variation in single-cell responses to SARS-CoV-2, Nature, 2023, 53 (8), pp.e2250307. ⟨10.1038/s41586-023-06422-9⟩.
-
2023Heterogeneity and functions of the 13 IFN-α subtypes – lucky for some?, Eur J Immunol 2023 Aug; 53(8): e2250307.
-
2023JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study., J Clin Immunol 2023 May; (): 1-12.
-
2023Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus., Ann Neurol 2023 Apr; 93(4): 643-654.
-
2023Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets., Cell Rep Med 2023 Jan; 4(1): 100894.
-
2022Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers., J Clin Immunol 2022 Dec; (): .
-
2022Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat Commun 2022 Nov; 13(1): 7254.
-
2022Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort., Cell Rep Med 2022 Nov; 3(11): 100804.
-
2022Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation., Cell Rep 2022 Jun; 39(13): 110989.
-
2022Variability of Primary Sjögren’s Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus., Arthritis Rheumatol 2022 Dec; 74(12): 1991-2002.
-
2022Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming., Ann Rheum Dis 2022 Jun; (): .
-
2022CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue., Pathogens 2022 Apr; 11(4): .
-
2022Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus., Acta Derm Venereol 2022 Mar; (): .
-
2022Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study., Rheumatology (Oxford) 2022 Feb; (): .
-
2022Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency., Blood 2022 02; (): .
-
2022Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old., EBioMedicine 2022 Feb; 76(): 103852.
-
2022Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses., Front Immunol 2022 ; 13(): 897193.
-
2021Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection., Nat Immunol 2021 Sep; 22(11):1428-1439.
-
2021Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection., J Clin Immunol 2021 Aug; (): .
-
2021Differential levels of IFNα subtypes in autoimmunity and viral infection., Cytokine 2021 Aug; 144(): 155533.
-
2021Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients., Sci Rep 2021 06; 11(1): 11886.
-
2021HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART., HIV Med 2021 May; 22(5): 397-408.
-
2021Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies., J Clin Immunol 2021 Apr; 41(3): 603-609.
-
2021JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study., Rheumatology (Oxford) 2021 Feb; (): .
-
2021Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients., J Allergy Clin Immunol Pract 2021 02; 9(2): 803-818.e11.
-
2021TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons., J Clin Invest 2021 Jan; 131(1): .
-
2021Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment., Front Immunol 2021 ; 12(): 628375.
-
2021Constitutive IFNα Protein Production in Bats., Front Immunol 2021 ; 12(): 735866.
-
2020Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling., J. Exp. Med. 2020 Nov; 217(11): .
-
2020Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa., 2020 Sep 24;140598..
-
2020Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus., Ann Neurol 2020 dec; 88(6): 1244-1250.
-
2020Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients., Science 2020 08; 369(6504): 718-724.
-
2020Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome., J. Clin. Immunol. 2020 Aug; 40(6): 807-819.
-
2020Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption., Schizophr. Res. 2020 Aug; 222: 484-486.
-
2020Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes., Diabetologia 2020 Aug; 63(8):1576-1587.
-
2020The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway, Haematologica 2020 Mar 21;105(12)2851-2854.
-
2020Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue., Front Immunol 2020 ; 11(): 605087.
-
2019Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in, Sci Immunol 2019 Dec;4(42).
-
2019Cardiac valve involvement in -related type I interferonopathy, J. Med. Genet. 2020 Jul;57(7):475-478.
-
2019PSMB10, the last immunoproteasome gene missing for PRAAS, J. Allergy Clin. Immunol. 2020 Mar;145(3):1015-1017.
-
2019Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling, Rheumatology (Oxford) 2019 Nov;.
-
2019Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage, Thorax 2020;75(1):92-95.
-
2019Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology, Rheumatology (Oxford) 2020 May 1;59(5):1191.
-
2019Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers, J. Autoimmun. 2020;106:102337.
-
2019Circulating interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity, 2020;72(1):195-197.
-
2019Plasma Type I IFN Protein Concentrations in Human Tuberculosis, Front Cell Infect Microbiol 2019;9:296.
-
2019Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment, Sci Adv 2019 Jul;5(7):eaav9019.
-
2019Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles, Arthritis Res. Ther. 2019 Jun;21(1):147.
-
2019IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay, Int. J. Med. Microbiol. 2019;309:299-306.
-
2019Delineating the healthy human skin UV response and early induction of interferon pathway in cutaneous lupus erythematosus, J. Invest. Dermatol. 2019 139:2058-2061.
-
2019Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined, Eur. J. Immunol. 2019 May;49(5):790-800.
-
2019Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth, Nat. Immunol. 2019 Mar;20(3):257-264.
-
2018Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome, N. Engl. J. Med. 2018 12;379(23):2275-7.
-
2018A child with severe juvenile dermatomyositis treated with ruxolitinib, Brain 2018 Nov;141(11):e80.
-
2018Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency, Ann. Rheum. Dis. 2018 Oct;.
-
2018First description of agonist and antagonist IP-10 in urine of patients with active TB, Int. J. Infect. Dis. 2019 Jan;78:15-21.
-
2018Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions, Front Immunol 2018;9:1456.
-
2018Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α, J Vis Exp 2018 06;(136).
-
2018JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis, Brain 2018 Jun;141(6):1609-1621.
-
2018Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou : mutations in result in a constitutive activation of type I interferon signalling, Ann. Rheum. Dis. 2018 Jun;.
-
2017Type I interferon-mediated autoinflammation due to DNase II deficiency, Nat Commun 2017 Dec;8(1):2176.
-
2017TBK1/IKKE blockade inhibits mutant STING mediated inflammatory response in patient cells, 2017 Apr;.
-
2017Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J. Exp. Med. 2017 May;214(5):1547-1555.
-
2013Structural and functional characterization of an orphan ATP-binding cassette ATPase involved in manganese utilization and tolerance in Leptospira spp, J. Bacteriol. 2013 Dec;195(24):5583-91.
-
2007The crystal structure of M. leprae ML2640c defines a large family of putative S-adenosylmethionine-dependent methyltransferases in mycobacteria, Protein Sci. 2007 Sep;16(9):1896-904.